HAND2 synergistically enhances transcription of dopamine-β -hydroxylase in the presence of Phox2a

Haiming Xu, Anthony Firulli, Xiaotong Zhang, Marthe J. Howard

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Noradrenergic neuronal identity and differentiation are controlled by cascades of transcription factors acting downstream of BMP4, including the basic helix-loop-helix DNA binding protein HAND2 and the homeodomain factor Phox2a. Dopamine-β-hydroxylase (DBH) is the penultimate enzyme required for synthesis of norepinephrine and is thus a noradrenergic cell type-specific marker. We have examined the interaction of HAND2 and Phox2a at the DBH promoter. Using transient transfection of P19 or NT-2 cells, HAND2 is shown to synergistically enhance Phox2a-driven transcriptional activity at the DBH promoter, an effect that is enhanced by cAMP. While mutation of the Phox2a homeodomain binding sites HD1, HD2, and HD3 results in the loss of HAND2/Phox2a transactivation of DBH, it is the interaction of HAND2/Phox2a at the CRE/AP1-HD1/2 domains in the DBH enhancer that are required for synergistic activation by HAND2. We find that HAND2 functions as a transcriptional activator without directly binding to E-box sequences in the DBH promoter, suggesting that HAND2-mediated DBH activity occurs by protein-protein interactions with other transcriptional regulators. Although we were unable to detect interaction of HAND2 and Phox2a in IP/Western blots, HAND2 synergistic activation of DBH is blocked by E1A, suggesting that HAND2 interacts with CBP (cAMP response element binding protein) in this transcriptional complex. In the presence of the putative HAND2 dimerization partner, E12, synergistic activation of DBH transcription is titrated away, suggesting that HAND2 does not functionally dimerize with E12 in the DBH transcription complex. Our data suggest that HAND2 regulates cell type-specific expression of norepinephrine in concert with Phox2a by a novel mechanism.

Original languageEnglish (US)
Pages (from-to)183-193
Number of pages11
JournalDevelopmental Biology
Volume262
Issue number1
DOIs
StatePublished - Oct 1 2003

Fingerprint

Mixed Function Oxygenases
Dopamine
Transcriptional Activation
Norepinephrine
E-Box Elements
Cyclic AMP Response Element-Binding Protein
DNA-Binding Proteins
Dimerization
Transfection
Proteins
Transcription Factors
Western Blotting
Binding Sites
Mutation
Enzymes

Keywords

  • cAMP
  • Cell type-specific gene expression
  • HAND2
  • Homeodomain core recognition sites
  • Neural crest
  • Noradrenergic differentiation
  • Phox2a
  • Sympathetic ganglion neurons

ASJC Scopus subject areas

  • Developmental Biology

Cite this

HAND2 synergistically enhances transcription of dopamine-β -hydroxylase in the presence of Phox2a. / Xu, Haiming; Firulli, Anthony; Zhang, Xiaotong; Howard, Marthe J.

In: Developmental Biology, Vol. 262, No. 1, 01.10.2003, p. 183-193.

Research output: Contribution to journalArticle

Xu, Haiming ; Firulli, Anthony ; Zhang, Xiaotong ; Howard, Marthe J. / HAND2 synergistically enhances transcription of dopamine-β -hydroxylase in the presence of Phox2a. In: Developmental Biology. 2003 ; Vol. 262, No. 1. pp. 183-193.
@article{2d7943c610ab478cbe793e13857b0db9,
title = "HAND2 synergistically enhances transcription of dopamine-β -hydroxylase in the presence of Phox2a",
abstract = "Noradrenergic neuronal identity and differentiation are controlled by cascades of transcription factors acting downstream of BMP4, including the basic helix-loop-helix DNA binding protein HAND2 and the homeodomain factor Phox2a. Dopamine-β-hydroxylase (DBH) is the penultimate enzyme required for synthesis of norepinephrine and is thus a noradrenergic cell type-specific marker. We have examined the interaction of HAND2 and Phox2a at the DBH promoter. Using transient transfection of P19 or NT-2 cells, HAND2 is shown to synergistically enhance Phox2a-driven transcriptional activity at the DBH promoter, an effect that is enhanced by cAMP. While mutation of the Phox2a homeodomain binding sites HD1, HD2, and HD3 results in the loss of HAND2/Phox2a transactivation of DBH, it is the interaction of HAND2/Phox2a at the CRE/AP1-HD1/2 domains in the DBH enhancer that are required for synergistic activation by HAND2. We find that HAND2 functions as a transcriptional activator without directly binding to E-box sequences in the DBH promoter, suggesting that HAND2-mediated DBH activity occurs by protein-protein interactions with other transcriptional regulators. Although we were unable to detect interaction of HAND2 and Phox2a in IP/Western blots, HAND2 synergistic activation of DBH is blocked by E1A, suggesting that HAND2 interacts with CBP (cAMP response element binding protein) in this transcriptional complex. In the presence of the putative HAND2 dimerization partner, E12, synergistic activation of DBH transcription is titrated away, suggesting that HAND2 does not functionally dimerize with E12 in the DBH transcription complex. Our data suggest that HAND2 regulates cell type-specific expression of norepinephrine in concert with Phox2a by a novel mechanism.",
keywords = "cAMP, Cell type-specific gene expression, HAND2, Homeodomain core recognition sites, Neural crest, Noradrenergic differentiation, Phox2a, Sympathetic ganglion neurons",
author = "Haiming Xu and Anthony Firulli and Xiaotong Zhang and Howard, {Marthe J.}",
year = "2003",
month = "10",
day = "1",
doi = "10.1016/S0012-1606(03)00361-0",
language = "English (US)",
volume = "262",
pages = "183--193",
journal = "Developmental Biology",
issn = "0012-1606",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - HAND2 synergistically enhances transcription of dopamine-β -hydroxylase in the presence of Phox2a

AU - Xu, Haiming

AU - Firulli, Anthony

AU - Zhang, Xiaotong

AU - Howard, Marthe J.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Noradrenergic neuronal identity and differentiation are controlled by cascades of transcription factors acting downstream of BMP4, including the basic helix-loop-helix DNA binding protein HAND2 and the homeodomain factor Phox2a. Dopamine-β-hydroxylase (DBH) is the penultimate enzyme required for synthesis of norepinephrine and is thus a noradrenergic cell type-specific marker. We have examined the interaction of HAND2 and Phox2a at the DBH promoter. Using transient transfection of P19 or NT-2 cells, HAND2 is shown to synergistically enhance Phox2a-driven transcriptional activity at the DBH promoter, an effect that is enhanced by cAMP. While mutation of the Phox2a homeodomain binding sites HD1, HD2, and HD3 results in the loss of HAND2/Phox2a transactivation of DBH, it is the interaction of HAND2/Phox2a at the CRE/AP1-HD1/2 domains in the DBH enhancer that are required for synergistic activation by HAND2. We find that HAND2 functions as a transcriptional activator without directly binding to E-box sequences in the DBH promoter, suggesting that HAND2-mediated DBH activity occurs by protein-protein interactions with other transcriptional regulators. Although we were unable to detect interaction of HAND2 and Phox2a in IP/Western blots, HAND2 synergistic activation of DBH is blocked by E1A, suggesting that HAND2 interacts with CBP (cAMP response element binding protein) in this transcriptional complex. In the presence of the putative HAND2 dimerization partner, E12, synergistic activation of DBH transcription is titrated away, suggesting that HAND2 does not functionally dimerize with E12 in the DBH transcription complex. Our data suggest that HAND2 regulates cell type-specific expression of norepinephrine in concert with Phox2a by a novel mechanism.

AB - Noradrenergic neuronal identity and differentiation are controlled by cascades of transcription factors acting downstream of BMP4, including the basic helix-loop-helix DNA binding protein HAND2 and the homeodomain factor Phox2a. Dopamine-β-hydroxylase (DBH) is the penultimate enzyme required for synthesis of norepinephrine and is thus a noradrenergic cell type-specific marker. We have examined the interaction of HAND2 and Phox2a at the DBH promoter. Using transient transfection of P19 or NT-2 cells, HAND2 is shown to synergistically enhance Phox2a-driven transcriptional activity at the DBH promoter, an effect that is enhanced by cAMP. While mutation of the Phox2a homeodomain binding sites HD1, HD2, and HD3 results in the loss of HAND2/Phox2a transactivation of DBH, it is the interaction of HAND2/Phox2a at the CRE/AP1-HD1/2 domains in the DBH enhancer that are required for synergistic activation by HAND2. We find that HAND2 functions as a transcriptional activator without directly binding to E-box sequences in the DBH promoter, suggesting that HAND2-mediated DBH activity occurs by protein-protein interactions with other transcriptional regulators. Although we were unable to detect interaction of HAND2 and Phox2a in IP/Western blots, HAND2 synergistic activation of DBH is blocked by E1A, suggesting that HAND2 interacts with CBP (cAMP response element binding protein) in this transcriptional complex. In the presence of the putative HAND2 dimerization partner, E12, synergistic activation of DBH transcription is titrated away, suggesting that HAND2 does not functionally dimerize with E12 in the DBH transcription complex. Our data suggest that HAND2 regulates cell type-specific expression of norepinephrine in concert with Phox2a by a novel mechanism.

KW - cAMP

KW - Cell type-specific gene expression

KW - HAND2

KW - Homeodomain core recognition sites

KW - Neural crest

KW - Noradrenergic differentiation

KW - Phox2a

KW - Sympathetic ganglion neurons

UR - http://www.scopus.com/inward/record.url?scp=0141459204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141459204&partnerID=8YFLogxK

U2 - 10.1016/S0012-1606(03)00361-0

DO - 10.1016/S0012-1606(03)00361-0

M3 - Article

VL - 262

SP - 183

EP - 193

JO - Developmental Biology

JF - Developmental Biology

SN - 0012-1606

IS - 1

ER -